GW Pharmaceuticals Plc has raised gross proceeds of $252 million on the US Nasdaq market with the issue of 2.8 million American Depositary Shares (ADSs) to investors at a price of $90 per ADS. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
